MDClone is a healthcare data exploration platform at the forefront of innovation. As a forward-thinking startup, MDClone is on a mission to reshape the global healthcare landscape.
Our vision is to help organizations harness the power of their data to drive impactful change for the betterment of patient health and clinical outcomes.
Founded in 2016 in Israel and headquartered in Beer Sheba, MDClone has forged strategic partnerships with major health systems, government entities, payers, and life science companies across the globe.
At MDClone, our primary focus is empowering healthcare institutions. We accelerate grassroots, data-driven innovation by enabling front-line staff to ask their own questions about their organization’s data. We foster stronger, more secure relationships between healthcare providers and life science companies. We also actively cultivate regional and global collaboration through our patented privacy solution.
The MDClone ADAMS Center, with the innovative ADAMS Platform at its core, serves as a hub for empowering clinical teams to lead meaningful change to care delivery by enabling rapid cycles of discovery at increasing volumes.
Featuring integration across a variety of source data systems and cutting-edge privacy capabilities, MDClone customers make their real-world data available to clinicians, researchers, and other collaborative entities.
When any user can efficiently access, analyze, and act on data, healthcare professionals can swiftly transform ideas into actionable insights and drive positive change in patient care.
MDClone’s commitment to excellence hasn’t gone unnoticed. We’re proud recipients of the Best Healthcare Big Data Platform award by the MedTech Breakthrough Awards in 2021, 2022 and 2023. Moreover, the World Economic Forum recognized the transformative potential of the MDClone ADAMS Platform and honored us as a Technology Pioneer in 2021. In the 2023 Black Book Awards, Black Book Research named MDClone the No. 1 quality, diagnosis, and treatment data platform for health systems.
Our impressive roster of clients includes esteemed institutions such as Washington University School of Medicine in St. Louis, Intermountain Healthcare, University of Chicago Medical Center, the VHA Innovation Ecosystem, The National Institutes of Health, The Ottawa Hospital, and Jewish-General Hospital in North America.
In Israel, MDClone is the leading healthcare data analytics company and proudly serves 100% of the healthcare market.
In Europe, MDClone is also serving Universitätsspital Basel in partnership with Roche to drive collaborative research efforts.
MDClone’s journey is powered by the support of influential investors in both the U.S. and Israel, including aMoon, Lightspeed, OrbiMed, Warburg Pincus, and Viola Growth.
Their confidence in our vision propels us forward as we continue to shape the future of healthcare through data-driven innovation.
Stay up-to-date with the latest healthcare innovations with the MDClone blog.
Discover how Stanford Health’s Suzanne Tamang, PhD, is using synthetic data to explore the connection between climate change and autoimmune diseases. This collaboration unlocks new insights, helping predict flare-ups and personalize care—paving the way for a more proactive approach to healthcare innovation.
Join us on our new blog where we celebrate the incredible ways our customers are transforming healthcare with our technology. From clinical innovations to operational breakthroughs, discover their stories and the value they’ve created.
